Search for:
Apr 25 2024
SCAFO Youth: Join us for the SCAVENGER HUNT at the Cully Community Fair this Saturday, April 27

Announcement for SCAFO Youth Group participants:

Join Us for a SCAVENGER HUNT this Saturday, April 27, 2024, at the Cully Community Resource Fair in Portland!

SCAFO Youth and one buddy can receive $50 each for completing the Optimal Health Scavenger Hunt at the Cully Community Fair in Portland!

Youth and their buddies should arrive by noon.

The fair runs from 11am-2pm, but our official youth gathering time will be Noon to 1pm.

Remember you MUST be registered with SCAFO’s Youth Group to participate! Contact Chuck Smith (charles@sicklecelloregon.org) or Pastor Marcia Taylor (marcia@sicklecelloregon.org) to sign up, and visit with us at the Cully Community Resource Fair this SATURDAY:

The Cully Community Resource Fair will be held at:

Hacienda CDC
6700 NE Killingsworth St, Portland, OR 97218
Saturday, April 27 2024
Guest time 11am-2pm

Rain or shine!!

Click below to download the event flyer in PDF file format:

Download the PDF in ENGLISH
Download the PDF in SPANISH
Download a PDF MAP of the site location.
Download SCAVENGER HUNT description

04.27.24 Hacienda CDC Fair Flyer English 04.27.24 Hacienda CDC Fair Flyer Spanish 04.27.24 Hacienda CDC Site Map

ScavengerHunt
____________________________

And DON’T FORGET to JOIN OUR MAILING LIST HERE

admin 0 Comments
Jan 8 2024
FDA Approves Genetic Treatments for Sickle Cell Disease

PORTLAND — The Sickle Cell Anemia Foundation of Oregon is excited by the news that two types of gene therapy for sickle cell have been approved by the FDA: Casgevy for “gene editing”, and Lyfgenia for “gene addition”.

The SCDAA has called gene therapy “potentially curative“, though, they warn, not everyone may be “eligible for gene therapy.”

Gene therapy involves a complex series of steps, including sampling and treating the patient’s stem cells, a regime of chemotherapy where the abnormal cells are removed, and an infusion of the patient’s own cells treated for sickle cell disease.

Patients who have undergone such treatments can expect acute episodes of the disease to diminish significantly over time as diseased blood cells are naturally replaced by healthy cells.

Candidates for sickle cell gene therapy must be evaluated against the dangerous effects of chemotherapy.

The FDA has approved both Casgevy and Lyfgenia for sickle cell patients ages 12 and up. The treatments are approved for sickle cell phenotypes SS and S-beta-zero.

SCDAA has more information here.

admin 0 Comments
Dec 22 2023
NEWS ALERT: Quaker Recalls Granola Bars and Granola Cereals Due to Possible Health Risk

CHICAGO, Illinois – December 15, 2023 – The Quaker Oats Company today announced the recall of specific granola bars and granola cereals listed below because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

The products listed below are sold throughout the 50 United States, Puerto Rico, Guam and Saipan. Consumers should check their pantries for any of the products listed below and dispose of them. Additionally, consumers with any product noted below can contact Quaker Consumer Relations (9 a.m. – 4:30 p.m. CST, Mon.-Fri.) at 1-800-492-9322 or visit www.quakergranolarecall.com for additional information or product reimbursement.

Read More

admin 0 Comments